8A41.1

ICD-11 MMS 2026-01

Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive

Description

MOG antibody associated spectrum disorders are inflammatory demyelinating diseases of the central nervous system with a predilection for optic nerve that include a subgroup of patients with bilateral optic neuritis (ON), longitudinally extensive (> 3 vertebral segments) myelitis (often recurrent) and rarely patients with an NMO like presentation. The clinical and immunopathological phenotype is under active investigation

Index terms

  • Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive
  • MOG antibody-positive neuromyelitis optica

Exclusions from above levels

  • 05 – Endocrine, nutritional or metabolic diseases
  • 18 – Complications of pregnancy, childbirth and the puerperium
  • 19 – Certain conditions originating in the perinatal period
Show allHide
  • 22 – Injury, poisoning or certain other consequences of external causes

Sibling codes

  • 8A41.0 – Transverse myelitis
  • 8A41.Y – Other specified isolated demyelinating syndromes of the central nervous system
  • 8A41.Z – Isolated demyelinating syndromes of the central nervous system, unspecified

Foundation entity

Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive – http://id.who.int/icd/entity/605048789

Part of: 8A41: Isolated demyelinating syndromes of the central nervous system › 08: Diseases of the nervous system